ATE158571T1 - Allophansäure derivate - Google Patents

Allophansäure derivate

Info

Publication number
ATE158571T1
ATE158571T1 AT94304553T AT94304553T ATE158571T1 AT E158571 T1 ATE158571 T1 AT E158571T1 AT 94304553 T AT94304553 T AT 94304553T AT 94304553 T AT94304553 T AT 94304553T AT E158571 T1 ATE158571 T1 AT E158571T1
Authority
AT
Austria
Prior art keywords
acid derivatives
allophanic acid
formula
pharmaceutically acceptable
allophanic
Prior art date
Application number
AT94304553T
Other languages
English (en)
Inventor
George Robert Brown
Eden Shute Richard
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of ATE158571T1 publication Critical patent/ATE158571T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/48—Y being a hydrogen or a carbon atom
    • C07C275/54—Y being a carbon atom of a six-membered aromatic ring, e.g. benzoylureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
AT94304553T 1993-06-28 1994-06-23 Allophansäure derivate ATE158571T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939313269A GB9313269D0 (en) 1993-06-28 1993-06-28 Allophanic acid derivatives

Publications (1)

Publication Number Publication Date
ATE158571T1 true ATE158571T1 (de) 1997-10-15

Family

ID=10737894

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94304553T ATE158571T1 (de) 1993-06-28 1994-06-23 Allophansäure derivate

Country Status (6)

Country Link
EP (1) EP0632020B1 (de)
JP (1) JPH0770046A (de)
AT (1) ATE158571T1 (de)
CA (1) CA2126038A1 (de)
DE (1) DE69405816T2 (de)
GB (2) GB9313269D0 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59409322D1 (de) * 1993-12-03 2000-06-08 Hoffmann La Roche Essigsäurederivate als Arzneimittel
EP1162194A1 (de) * 2000-06-06 2001-12-12 Aventis Pharma Deutschland GmbH Auf Faktor VIIa inhibitorisch wirkende (Thio)-Harnstoff Verbindungen, Verfahren zu deren Herstellung und deren Verwendung
CN111683976B (zh) 2018-02-05 2022-11-18 生物辐射实验室股份有限公司 具有阴离子交换-疏水混合模式配体的色谱树脂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3378207D1 (en) * 1983-01-24 1988-11-17 Duphar Int Res Benzoylurea compounds and pesticidal compositions comprisingsame
AU642524B2 (en) * 1990-09-10 1993-10-21 Duphar International Research B.V. Pharmaceutical formulation containing a benzoyl urea derivative
US5272162A (en) * 1992-07-02 1993-12-21 G. D. Searle & Co. Platelet aggregation inhibitors

Also Published As

Publication number Publication date
DE69405816T2 (de) 1998-01-15
JPH0770046A (ja) 1995-03-14
CA2126038A1 (en) 1994-12-29
DE69405816D1 (de) 1997-10-30
EP0632020B1 (de) 1997-09-24
GB9412495D0 (en) 1994-08-10
EP0632020A1 (de) 1995-01-04
GB9313269D0 (en) 1993-08-11

Similar Documents

Publication Publication Date Title
BG103297A (en) Aralkyl and aralkyliden heterocyclic lactams and imides
IL100015A0 (en) Mono-n-substituted 1,4,7,10-tetraazacyclododecane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DK0392317T3 (da) Benzimidazoler, lægemidler indeholdende disse forbindelser og fremgangsmåder til deres fremstilling
BR9406613A (pt) Composto éster ou amida metabolicamente lábil do mesmo processo para a preparação de um composto e composição farmacêutica
IL98933A0 (en) Benzimidazoles,their preparation and pharmaceutical compositions containing them
IL101779A0 (en) Fibrinogen receptor antagonists and pharmaceutical compositions containing them
PH25504A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides pharmaceutical composition containing said compound, method of use thereof
IL102759A0 (en) Hydantoin derivatives,their preparation and pharmaceutical compositions containing them
IL94662A0 (en) N-substituted lauramides,their preparation and pharmaceutical compositions containing them
NZ234501A (en) Hemoregulatory peptides and pharmaceutical compositions containing them
ATE158570T1 (de) Acylharnstoffe
DE69405816D1 (de) Allophansäure Derivate
IL131216A (en) Drugs inhibiting progress of pterygium and postoperative recurrence of the same
DK0552765T3 (da) benzimidazoler, farmaceutiske præparater indeholdende disse og fremgangsmåde til deres fremstilling
IL97698A0 (en) Hydroxymethyl-indolizidines,quinolizidines and pharmaceutical compositions containing same
TW267156B (de)
IL90879A0 (en) 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties